GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PuriBlood Medical Co Ltd (ROCO:6847) » Definitions » Capex-to-Operating-Income

PuriBlood Medical Co (ROCO:6847) Capex-to-Operating-Income : 0.00 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PuriBlood Medical Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

PuriBlood Medical Co's Capital Expenditure for the six months ended in Jun. 2024 was NT$-1.14 Mil. Its Operating Income for the six months ended in Jun. 2024 was NT$-13.45 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


PuriBlood Medical Co Capex-to-Operating-Income Historical Data

The historical data trend for PuriBlood Medical Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuriBlood Medical Co Capex-to-Operating-Income Chart

PuriBlood Medical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial - - - 1.59 -

PuriBlood Medical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1.37 - - - -

Competitive Comparison of PuriBlood Medical Co's Capex-to-Operating-Income

For the Diagnostics & Research subindustry, PuriBlood Medical Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PuriBlood Medical Co's Capex-to-Operating-Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PuriBlood Medical Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where PuriBlood Medical Co's Capex-to-Operating-Income falls into.



PuriBlood Medical Co Capex-to-Operating-Income Calculation

PuriBlood Medical Co's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-6.348) / -50.403
=N/A

PuriBlood Medical Co's Capex-to-Operating-Income for the quarter that ended in Jun. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-1.144) / -13.448
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PuriBlood Medical Co  (ROCO:6847) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


PuriBlood Medical Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of PuriBlood Medical Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


PuriBlood Medical Co Business Description

Traded in Other Exchanges
N/A
Address
Gongye E. 9th Road, Baoshan Township, 2nd Floor, No.11, Hsinchu County, Baoshan, TWN
PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology provides protection to support living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Seperation, and P-tex.

PuriBlood Medical Co Headlines

No Headlines